BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00095459
First received: November 4, 2004
Last updated: October 4, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)